Evidence map›Paper›PMID 32680963›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Morphological profiling of tubercle bacilli identifies drug pathways of action.

Trever C Smith, Krista M Pullen, Michaela C Olson, Morgan E McNellis, Ian Richardson, Sophia Hu, Jonah Larkins-Ford, Xin Wang, Joel S Freundlich, D Michael Ando and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Deep learning-driven bacterial cytological profiling to determine antimicrobial mechanisms inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Transcriptomic responses to antibiotic exposure inAntimicrobial agents and chemotherapy · 2024
    Article
  13. Aerosolization of viableProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Review
  15. Review
  16. Article
  17. Molecular Mechanisms of MmpL3 Function and Inhibition.Microbial drug resistance (Larchmont, N.Y.) · 2023
    Review
  18. Types and functions of heterogeneity in mycobacteria.Nature reviews. Microbiology · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Trever C SmithDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA 02111.ORCID 0000-0002-1651-313X
Krista M PullenDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA 02111.ORCID 0000-0002-4857-8907
Michaela C OlsonDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA 02111.ORCID 0000-0002-7299-8362
Morgan E McNellisDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA 02111.ORCID 0000-0002-6055-262X
Ian RichardsonDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA 02111.
Sophia HuDepartment of Bioinformatics and Computational Biology, University of Maryland, Baltimore County, Baltimore, MD 21250.ORCID 0000-0002-5950-388X
Jonah Larkins-FordDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA 02111.ORCID 0000-0001-9123-9508
Xin WangDepartment of Pharmacology, Physiology, and Neuroscience, Rutgers University-New Jersey Medical School, Newark, NJ 07103.ORCID 0000-0002-6930-3347
Joel S FreundlichDepartment of Pharmacology, Physiology, and Neuroscience, Rutgers University-New Jersey Medical School, Newark, NJ 07103.ORCID 0000-0002-3411-3455
D Michael AndoApplied Science Team, Google Research, Mountain View, CA 94043.ORCID 0000-0001-9022-8444
Bree B AldridgeDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA 02111; bree.aldridge@tufts.edu.ORCID 0000-0003-2236-1424
Tufts University · USRutgers, The State University of New Jersey · USGoogle (United States) · USUniversity of Maryland, Baltimore County · US

Funding

Therapeutics for drug resistant-bacteria: Arylpropionyl-phloroglucinolsU19AI109713 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI PERLIN, DAVID S · 2014 to 2018
$26.9M
TRANSLATIONAL PHARMACOLOGY COREP50GM107618 · NIGMS · HARVARD MEDICAL SCHOOL · PI SORGER, PETER KARL · 2014 to 2018
$10.8M
MOLECULAR ANALYSIS OF MICROBIAL PATHOGENST32AI007422 · NIAID · TUFTS UNIVERSITY BOSTON · PI Ralph R. Isberg · 1992 to 2026
$5.7M
Infectious Disease Training-Pathogenesis/Host ResponseT32AI007329 · NIAID · TUFTS MEDICAL CENTER · PI HU, LINDEN T · 1988 to 2018
$4.1M
Quantitative Design of Multi-drug Regiments for TuberculosisDP2LM011952 · NLM · TUFTS UNIVERSITY BOSTON · PI ALDRIDGE, BREE BEARDSLEY · 2013 to 2018
$2.9M
NIAID NIH HHS T32 AI007329NIAID NIH HHS T32 AI007422NIAID NIH HHS U19 AI109713NIGMS NIH HHS P50 GM107618NLM NIH HHS DP2 LM011952
6 · The paper itself

Abstract

Morphological profiling is a method to classify target pathways of antibacterials based on how bacteria respond to treatment through changes to cellular shape and spatial organization. Here we utilized the cell-to-cell variation in morphological features of

Indexed as

Mycobacterium tuberculosisSoftwareAntitubercular AgentsCell WallDiarylquinolinesDrug DiscoveryHigh-Throughput Screening AssaysTranscriptomeAntitubercular AgentsbedaquilineDiarylquinolinescell morphologydrug discoveryhigh throughputtuberculosis

Identifiers

PMID32680963
PMCPMC7414088
OpenAlexW3042810913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.